Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Ранг среди акций
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Цена акции
$4.87
Рыночная капитализация
$4.36B
Изменение (1 день)
-5.47%
Изменение (1 год)
-15.62%
Страна
CN
Торговля Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Категория
Healthcare
История дивидендной доходности для Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Дивидендная доходность (TTM) компании Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (тикер: 688336) на 2024-12-31 составляет: 0.39%
Средняя дивидендная доходность за последние 5 лет: 0.14%
Средняя дивидендная доходность за последние 5 лет: 0.14%
История дивидендной доходности компании Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336) с 2006 по 2026
Дивидендная доходность на конец каждого года (TTM)
| Год | Дивидендная доходность | Изменить |
|---|---|---|
| 2026 (TTM) | 1.49% | 396.67% |
| 2025 | 0.30% | -23.08% |
| 2024 | 0.39% | 3,800.00% |
| 2023 | 0.01% | -50.00% |
| 2022 | 0.02% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | 2.48% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | -100.00% |
| 2012 | 0.04% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | 0.01% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | 0.00% |
Дивидендная доходность (TTM) аналогичных компаний или конкурентов
| Компания | Дивидендная доходность | Страна |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.07% |
AU
|
|
| 0.56% |
BE
|
|
| 0.00% |
NL
|
